These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17571566)

  • 1. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
    Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
    Kane SV; Bharadwaj R; Tongaonkar HB
    Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian serous tumors of limited malignancy and invasive peritoneal implants. Review of the literature].
    Fondrinier E; Seince N; Verriele V; Lorimier G; Gamelin E
    Contracept Fertil Sex; 1999 Nov; 27(11):780-4. PubMed ID: 10609410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline tumors of the ovary and peritoneal implants.
    Denkert C; Dietel M
    Verh Dtsch Ges Pathol; 2005; 89():84-91. PubMed ID: 18035677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathology of and controversial aspects of ovarian borderline tumours.
    McCluggage WG
    Curr Opin Oncol; 2010 Sep; 22(5):462-72. PubMed ID: 20531187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants.
    Deffieux X; Morice P; Camatte S; Fourchotte V; Duvillard P; Castaigne D
    Gynecol Oncol; 2005 Apr; 97(1):84-9. PubMed ID: 15790442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
    Pisharodi LR; Bedrossian CW
    Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
    Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
    Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological evaluation on ovarian serous borderline tumours and their implants].
    Guo L; Lian L; Liu T
    Zhonghua Fu Chan Ke Za Zhi; 1996 May; 31(5):287-90. PubMed ID: 9206182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors and treatment for advanced-stage borderline ovarian tumors].
    Morice P; Camatte S; Rouzier R; Pautier P; Atallah D; Pomel C; Lhomme C; Duvillard P; Castaigne D
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):623-8. PubMed ID: 12457134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of elastin staining in the assessment of peritoneal implants associated with ovarian serous borderline tumours.
    Stewart CJ; Brennan BA; Crook ML; Russell P
    Histopathology; 2007 Sep; 51(3):313-21. PubMed ID: 17727474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
    Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
    Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serious ovarian tumors and extra-ovarian peritoneal tumors of the same histology].
    Kunz J; Rondez R
    Praxis (Bern 1994); 1998 Feb; 87(6):191-8. PubMed ID: 9531813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants.
    Sieben NL; Roemen GM; Oosting J; Fleuren GJ; van Engeland M; Prat J
    J Pathol; 2006 Dec; 210(4):405-11. PubMed ID: 17096315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.